本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

42.13
+11.4337.23%
盘后42.370.2400+0.57%19:59 EDT
成交量:1,494.49万
成交额:6.25亿
市值:38.86亿
市盈率:-147.13
高:43.31
开:41.53
低:39.90
收:30.70
52周最高:43.31
52周最低:13.88
股本:9,224.16万
流通股本:9,122.00万
量比:7.99
换手率:16.38%
股息:- -
股息率:- -
每股收益(TTM):-0.2864
每股收益(LYR):-0.2864
净资产收益率:-57.80%
总资产收益率:-6.55%
市净率:33.84
市盈率(LYR):-147.13

数据加载中...

2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report